PIPELINE WATCH Latanoprost SPC ends in top EU markets n mid-January, Pfizer’s blockbuster treatment for glaucoma and ocular hypertension, Xalatan (latanoprost), loses supplementary protection certificate (SPC) exclusi

First Page		Document Content
Date: 2012-01-23 01:55:50		PIPELINE WATCH Latanoprost SPC ends in top EU markets n mid-January, Pfizer’s blockbuster treatment for glaucoma and ocular hypertension, Xalatan (latanoprost), loses supplementary protection certificate (SPC) exclusi Add to Reading List Source URL: www.genericsweb.com Download Document from Source Website File Size: 37,90 KB Share Document on Facebook